CONTEXT: Few large-scale, multisite investigations have assessed the development of posttraumatic stress disorder (PTSD) symptoms and health outcomes across the spectrum of patients with mild, moderate, and severe traumatic brain injury (TBI). OBJECTIVES: To understand the risk of developing PTSD symptoms and to assess the impact of PTSD on the development of health and cognitive impairments across the full spectrum of TBI severity. DESIGN: Multisite US prospective cohort study. SETTING: Eighteen level I trauma centers and 51 non-trauma center hospitals. PATIENTS: A total of 3047 (weighted n = 10 372) survivors of multiple traumatic injuries between the ages of 18 and 84 years. MAIN OUTCOME MEASURES: Severity of TBI was categorized from chart-abstracted International Classification of Diseases, Ninth Revision, Clinical Modification codes. Symptoms consistent with a DSM-IV diagnosis of PTSD were assessed with the PTSD Checklist 12 months after injury. Self-reported outcome assessment included the 8 Medical Outcomes Study 36-Item Short Form Health Survey health status domains and a 4-item assessment of cognitive function at telephone interviews 3 and 12 months after injury. RESULTS: At the time of injury hospitalization, 20.5% of patients had severe TBI, 11.7% moderate TBI, 12.9% mild TBI, and 54.9% no TBI. Patients with severe (relative risk, 0.72; 95% confidence interval, 0.58-0.90) and moderate (0.63; 0.44-0.89) TBI, but not mild TBI (0.83; 0.61-1.13), demonstrated a significantly diminished risk of PTSD symptoms relative to patients without TBI. Across TBI categories, in adjusted analyses patients with PTSD demonstrated an increased risk of health status and cognitive impairments when compared with patients without PTSD. CONCLUSIONS: More severe TBI was associated with a diminished risk of PTSD. Regardless of TBI severity, injured patients with PTSD demonstrated the greatest impairments in self-reported health and cognitive function. Treatment programs for patients with the full spectrum of TBI severity should integrate intervention approaches targeting PTSD.
CONTEXT: Few large-scale, multisite investigations have assessed the development of posttraumatic stress disorder (PTSD) symptoms and health outcomes across the spectrum of patients with mild, moderate, and severe traumatic brain injury (TBI). OBJECTIVES: To understand the risk of developing PTSD symptoms and to assess the impact of PTSD on the development of health and cognitive impairments across the full spectrum of TBI severity. DESIGN: Multisite US prospective cohort study. SETTING: Eighteen level I trauma centers and 51 non-trauma center hospitals. PATIENTS: A total of 3047 (weighted n = 10 372) survivors of multiple traumatic injuries between the ages of 18 and 84 years. MAIN OUTCOME MEASURES: Severity of TBI was categorized from chart-abstracted International Classification of Diseases, Ninth Revision, Clinical Modification codes. Symptoms consistent with a DSM-IV diagnosis of PTSD were assessed with the PTSD Checklist 12 months after injury. Self-reported outcome assessment included the 8 Medical Outcomes Study 36-Item Short Form Health Survey health status domains and a 4-item assessment of cognitive function at telephone interviews 3 and 12 months after injury. RESULTS: At the time of injury hospitalization, 20.5% of patients had severe TBI, 11.7% moderate TBI, 12.9% mild TBI, and 54.9% no TBI. Patients with severe (relative risk, 0.72; 95% confidence interval, 0.58-0.90) and moderate (0.63; 0.44-0.89) TBI, but not mild TBI (0.83; 0.61-1.13), demonstrated a significantly diminished risk of PTSD symptoms relative to patients without TBI. Across TBI categories, in adjusted analyses patients with PTSD demonstrated an increased risk of health status and cognitive impairments when compared with patients without PTSD. CONCLUSIONS: More severe TBI was associated with a diminished risk of PTSD. Regardless of TBI severity, injured patients with PTSD demonstrated the greatest impairments in self-reported health and cognitive function. Treatment programs for patients with the full spectrum of TBI severity should integrate intervention approaches targeting PTSD.
Authors: Douglas F Zatzick; Gregory J Jurkovich; Ming-Yu Fan; David Grossman; Joan Russo; Wayne Katon; Frederick P Rivara Journal: Arch Pediatr Adolesc Med Date: 2008-07
Authors: Adrienne J Heinz; David L Pennington; Nicole Cohen; Brandi Schmeling; Brooke A Lasher; Emily Schrodek; Steven L Batki Journal: Mil Med Date: 2016-07 Impact factor: 1.437
Authors: Linda Ewing-Cobbs; Mary R Prasad; Charles S Cox; Douglas A Granger; Gerardo Duque; Paul R Swank Journal: Psychoneuroendocrinology Date: 2017-06-10 Impact factor: 4.905
Authors: Linda Ewing-Cobbs; Dana DeMaster; Christopher G Watson; Mary R Prasad; Charles S Cox; Larry A Kramer; Jesse T Fischer; Gerardo Duque; Paul R Swank Journal: J Neurotrauma Date: 2019-03-06 Impact factor: 5.269
Authors: Douglas Zatzick; Dennis M Donovan; Gregory Jurkovich; Larry Gentilello; Chris Dunn; Joan Russo; Jin Wang; Christopher D Zatzick; Jeff Love; Collin McFadden; Frederick P Rivara Journal: Addiction Date: 2014-02-28 Impact factor: 6.526
Authors: Paul E Rapp; Brenna M Rosenberg; David O Keyser; Dominic Nathan; Kevin M Toruno; Christopher J Cellucci; Alfonso M Albano; Scott A Wylie; Douglas Gibson; Adele M K Gilpin; Theodore R Bashore Journal: Front Neurol Date: 2013-07-22 Impact factor: 4.003
Authors: Douglas Zatzick; Gregory Jurkovich; Frederick P Rivara; Joan Russo; Amy Wagner; Jin Wang; Chris Dunn; Sarah Peregrine Lord; Megan Petrie; Stephen S Oʼconnor; Wayne Katon Journal: Ann Surg Date: 2013-03 Impact factor: 12.969
Authors: J Douglas Bremner; Matthew T Wittbrodt; Amit J Shah; Bradley D Pearce; Nil Z Gurel; Omer T Inan; Paolo Raggi; Tené T Lewis; Arshed A Quyyumi; Viola Vaccarino Journal: J Nerv Ment Dis Date: 2020-03 Impact factor: 2.254
Authors: Juliet Haarbauer-Krupa; Christopher A Taylor; John K Yue; Ethan A Winkler; Romain Pirracchio; Shelly R Cooper; John F Burke; Murray B Stein; Geoffrey T Manley Journal: J Neurotrauma Date: 2016-06-10 Impact factor: 5.269